D.A. Davidson & Co. Alnylam Pharmaceuticals, Inc. Transaction History

D.A. Davidson & Co.

$12 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$151.41 - $196.57 $29,070 - $37,741	-192 Reduced 5.84%	3,098 $592,000
Q3 2023 Nov 08, 2023	BUY	$170.77 - $211.65 $9,733 - $12,064	57 Added 1.76%	3,290 $582,000
Q2 2023 Aug 10, 2023	BUY	$185.01 - $212.05 $3,700 - $4,241	20 Added 0.62%	3,233 $614,000
Q1 2023 Apr 25, 2023	SELL	$182.66 - $235.53 $6,575 - $8,479	-36 Reduced 1.11%	3,213 $643,000
Q4 2022 Feb 03, 2023	BUY	$185.53 - $241.31 $50,649 - $65,877	273 Added 9.17%	3,249 $772,000
Q3 2022 Nov 07, 2022	SELL	$138.54 - $232.0 $153,086 - $256,360	-1,105 Reduced 27.08%	2,976 $596,000
Q2 2022 Jul 28, 2022	BUY	$120.42 - $169.29 $12,042 - $16,929	100 Added 2.51%	4,081 $595,000
Q1 2022 May 12, 2022	SELL	$127.18 - $173.91 $31,540 - $43,129	-248 Reduced 5.86%	3,981 $650,000
Q4 2021 Jan 31, 2022	BUY	$159.56 - $209.29 $29,837 - $39,137	187 Added 4.63%	4,229 $717,000
Q3 2021 Nov 15, 2021	BUY	$169.75 - $207.73 $29,027 - $35,521	171 Added 4.42%	4,042 $763,000
Q2 2021 Aug 10, 2021	BUY	$128.63 - $176.89 $31,642 - $43,514	246 Added 6.79%	3,871 $656,000
Q1 2021 May 07, 2021	BUY	$126.83 - $175.69 $96,771 - $134,051	763 Added 26.66%	3,625 $512,000
Q4 2020 Feb 10, 2021	BUY	$122.97 - $147.0 $77,717 - $92,904	632 Added 28.34%	2,862 $372,000
Q3 2020 Nov 02, 2020	BUY	$121.19 - $165.49 $26,782 - $36,573	221 Added 11.0%	2,230 $325,000
Q2 2020 Aug 10, 2020	BUY	$104.21 - $156.44 $8,128 - $12,202	78 Added 4.04%	2,009 $298,000
Q1 2020 May 05, 2020	BUY	$93.12 - $133.99 $179,814 - $258,734	1,931 New	1,931 $210,000
Q3 2017 Nov 08, 2017	SELL	$72.53 - $118.27 $10,879 - $17,740	-150 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	150	150 $0

Others Institutions Holding ALNY

# of Institutions

644

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

Capital World Investors Los Angeles, CA

16.5M
Shares

$3.87 Billion
0.73% of portfolio
Vanguard Group Inc Valley Forge, PA

12.6M
Shares

$2.96 Billion
0.06% of portfolio
Black Rock Inc. New York, NY

9.55M
Shares

$2.24 Billion
0.05% of portfolio
Capital Research Global Investors Los Angeles, CA

5.24M
Shares

$1.23 Billion
0.31% of portfolio
Wellington Management Group LLP Boston, MA

4.95M
Shares

$1.16 Billion
0.24% of portfolio

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $28.8B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.

Account